Brown-Forman Corporation Class B (BF.B) Stock Price Today
Aura AI Summary
Key Stats
- $14.22BMarket Cap
- 1,939,967Volume
- Consumer StaplesSector
- $30.9652W High
- $22.8052W Low
- 59 DaysTypical Hold Time
- $16.36BEnterprise Value
- 3.01%Div Yield
- -Trading Activity
Track Brown-Forman Corporation Class B (BF.B) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Brown-Forman Corporation Class B has traded between a low of $22.8 and a high of $30.96, highlighting its annual price range. Buy and sell Brown-Forman Corporation Class B shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Brown-Forman Corporation Class B
Brown-Forman is the largest U.S.-domiciled producer of distilled spirits. The firm reports only a single operating segment, and whiskey represents its primary business driver, generating roughly three-quarters of sales, undergirded by the Jack Daniel's brand as well as bourbons such as Woodford Reserve and Old Forrester. Notable nonwhiskey offerings include tequilas such as el Jimador and Herradura. The firm operates globally, with products sold in more than 170 countries, and adapts its route-to-consumer model depending on regulation as well as the prevailing competitive dynamics in a given market. For example, it sells through distributors in the U.S. but operates its own logistics apparatus in many other countries. The company remains under the control of the Brown family.
Most Recent News
Infoblox launches Australia realm on AWS for local DDI management and security.
Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

European Commission approves RASONQUE for metastatic pancreatic cancer treatment
The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

MLCommons releases MLPerf Training v6.1 with new AI benchmarks and record participation.
MLCommons announced the MLPerf Training v6.1 benchmark results, introducing two new benchmarks focused on recommender systems and large-scale post-training for AI. This release highlights advances in AI training architectures and a growing diversity ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.